Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 15/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.82 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinaprilat SCHEMBL7392611 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL11306348 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL29598971 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL11286565 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL11286571 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL7421419 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL6438000 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL9253792 | 1.00 | ACE (1.00) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL27697059 | 0.99 | ACE (0.98) | ACEABCB11PDE3A | |
| Quinaprilat SCHEMBL27717008 | 0.99 | ACE (0.98) | ACEABCB11PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4084 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250082608-A1 | TREATMENT AND PREVENTION OF GLOMERULAR DISEASE | SINGAPORE HEALTH SERVICES PTE LTD. (SG) | 2025-03-13 | — | — | US | claimed |
| EP-4448096-A1 | TREATMENT AND PREVENTION OF GLOMERULAR DISEASE | Singapore Health Services Pte. Ltd. (SG) | 2024-10-23 | — | — | EP | claimed |
| EP-3474836-B1 | SALBUTAMOL-CONTAINING OPHTHALMIC MEDICAMENT | REKIK RAOUF (TN) | 2024-01-17 | — | — | EP | claimed |
| WO-2023111196-A1 | TREATMENT AND PREVENTION OF GLOMERULAR DISEASE | SINGAPORE HEALTH SERVICES PTE. LTD. (SG) | 2023-06-22 | — | — | WO | claimed |
| CN-116234545-A | Composition of fixed dose SGLT-2 inhibitor and angiotensin converting enzyme inhibitor and application | 北京睿创康泰医药研究院有限公司 | 2023-06-06 | — | — | CN | claimed |
| WO-2022104621-A1 | FIXED-DOSE COMBINATION OF SGLT-2 INHIBITOR AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND USE THEREOF | 北京睿创康泰医药研究院有限公司 | 2022-05-27 | — | — | WO | claimed |
| EP-1778234-B2 | PIMOBENDAN TO BE USED FOR THE REDUCTION OF HEART SIZE IN MAMMALS SUFFERING FROM HEART FAILURE | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2021-06-23 | — | — | EP | claimed |
| US-20200375515-A1 | BIOINTERFACE MEMBRANES INCORPORATING BIOACTIVE AGENTS | DEXCOM, INC. | 2020-12-03 | — | — | US | claimed |
| EP-2034951-B2 | REHYDRATABLE PHARMACEUTICAL PRODUCT | BIOCOMPATIBLES UK LTD (GB) | 2020-03-25 | — | — | EP | claimed |
| US-10537588-B2 | Use of pimobendan for the reduction of heart size in mammals suffering from heart failure | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2020-01-21 | — | — | US | claimed |
| WO-1996024372-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR, SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST AND DIURETIC | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024373-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1994028924-A1 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND AII ANTAGONISTS | LABORATOIRES MERCK SHARP ET DOHME CHIBRET (FR) | 1994-12-22 | — | — | WO | claimed |
| EP-0629408-A1 | Combination of angiotensin converting enzyme inhibitors and AII antagonists | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET (FR) | 1994-12-21 | — | — | EP | claimed |
| EP-0600033-A1 | DOSAGE FORM FOR DELIVERING DRUG IN SHORT-TIME PERIOD. | ALZA CORP (US) | 1994-06-08 | — | — | EP | claimed |
| WO-1993003711-A1 | DOSAGE FORM FOR DELIVERING DRUG IN SHORT-TIME PERIOD | ALZA CORPORATION (US) | 1993-03-04 | — | — | WO | claimed |
| US-5178867-A | Dosage form for delivering drug in short-time period | ALZA CORPORATION (US) | 1993-01-12 | — | — | US | claimed |
| EP-0391462-A1 | Synergistic compositions containing ketanserin | JANSSEN PHARMACEUTICA N.V. (BE) | 1990-10-10 | — | — | EP | claimed |
| EP-0220107-A2 | Use of angiotensin-converting enzyme inhibitors in macular degeneration | MERCK & CO. INC. (US) | 1987-04-29 | — | — | EP | claimed |
| US-4656188-A | Ace inhibitors in macular degeneration | MERCK & CO., INC. (US) | 1987-04-07 | — | — | US | claimed |